Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer

Figure 2 Prognostic value of the signature containing 8 necroptosis-related long noncoding RNAs for the Cancer Genome Atlas-colorectal cancer cohort. A: Display of the necroptosis-related long noncoding RNA (lncRNA) signature based on the risk score; B: Survival time and survival status comparisons between the high- and low-risk groups; C: Heatmap of the expression of 8 lncRNAs in the different groups and the relationships between clinicopathological characteristics and the RS. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001.